Use of miRNA Response Sequences to Block Off-Target Replication and Increase the Safety of an Unattenuated, Glioblastoma-Targeted Oncolytic HSV
Molecular Therapy- United States
doi 10.1038/mt.2014.177
Full Text
Abstract
Available in
Date
January 1, 2015
Authors
Publisher
Elsevier BV